LoadingHTZ
Davis Robert Emerson reported 58,593 shares of Common Stock in HERTZ GLOBAL HOLDINGS, INC as grants or awards dated 2026-11-02. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
HTZ
Hinrichs Joseph R reported 56,616 shares of Common Stock in HERTZ GLOBAL HOLDINGS, INC as grants or awards dated 2026-11-02. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
HTZ
Larsen Nils Erik reported 58,593 shares of Common Stock in HERTZ GLOBAL HOLDINGS, INC as grants or awards dated 2026-11-02. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
TAK
Bitetti Teresa Marie reported Sale in TAKEDA PHARMACEUTICAL CO LTD: 46609 units of American Depositary Shares, dated 2026-11-02. The full Form 4 contains 1 transaction entry.
MTRX
Bustamante Jose Luis M. reported 10,325 shares of Common Stock in MATRIX SERVICE CO as grants or awards dated 2026-11-03. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
MTRX
Carnes Martha Z. reported 10,325 shares of Common Stock in MATRIX SERVICE CO as grants or awards dated 2026-11-03. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
MTRX
CHANDLER JOHN D reported 10,325 shares of Common Stock in MATRIX SERVICE CO as grants or awards dated 2026-11-03. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
CSHR
Masters Daniel reported Sale in CoinShares PLC: 33333 units of Ordinary Shares, dated 2026-11-02. The full Form 4 contains 3 transaction entries.
VRSN
BIDZOS D JAMES reported Sale in VERISIGN INC/CA: 1160 units of Common Stock, dated 2026-11-03. The full Form 4 contains 8 transaction entries.
SAIA
Fowler Todd C. reported Grant or award in SAIA INC: 226.00 units of Common Stock, dated 2026-11-02. The full Form 4 contains 1 transaction entry.
RXRX
Borgeson Blake reported Sale in RECURSION PHARMACEUTICALS, INC.: 40000 units of Class A Common Stock, dated 2026-11-03. The full Form 4 contains 1 transaction entry.
RXRX
Hassan Fred reported 156,658 shares of Class A Common Stock in RECURSION PHARMACEUTICALS, INC. as grants or awards dated 2026-11-02. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
CUBI
Way T Lawrence reported Sale in Customers Bancorp, Inc.: 48796.00 units of Common Stock, dated 2026-10-30. The full Form 4 contains 2 transaction entries.
GATX
Holmes John McClain III reported Grant or award in GATX CORP: 142.00 units of Common Stock, dated 2026-11-02. The full Form 4 contains 1 transaction entry.
CUBI
Watkins Philip reported Exercise or conversion in Customers Bancorp, Inc.: 2000.00 units of Common Stock, dated 2026-11-02. The full Form 4 contains 3 transaction entries.
JBSS
Finn Michael J reported Purchase in SANFILIPPO JOHN B & SON INC: 200 units of Common Stock, dated 2026-11-04. The full Form 4 contains 2 transaction entries.
MXF
Saba Capital Management, L.P. reported Purchase in MEXICO EQUITY & INCOME FUND INC: 13804 units of Common Stock, dated 2026-11-03. The full Form 4 contains 1 transaction entry.
AZR
Davidson Matt reported Conversion in Azora Therapeutics, Inc. (DE): 524954 units of Common Stock, dated 2026-11-02. The full Form 4 contains 4 transaction entries.
RUN
Barak Maria reported Sale in Sunrun Inc.: 3256 units of Common Stock, dated 2026-11-04. The full Form 4 contains 1 transaction entry.
Benner Gaylord reported Grant or award in GREIF, INC: 2741 units of Restricted Stock Unit (derivative), dated 2026-11-02. The full Form 4 contains 1 transaction entry.
XERS
Taddese Menassie reported Grant or award in Xeris Biopharma Holdings, Inc.: 22365 units of Common Stock, dated 2026-11-02. The full Form 4 contains 2 transaction entries.
WPC
Zander Brian H reported 100 shares of Common Stock in W. P. Carey Inc. as grants or awards dated 2026-11-04. The Form 4 was disclosed on Nov 4, 2026. These were stock awards, not open-market purchases.
JBLU
Mittal Nik reported Purchase in JETBLUE AIRWAYS CORP: 31300 units of Common Stock, dated 2026-11-03. The full Form 4 contains 2 transaction entries.
XERS
Hecht Beth reported Sale in Xeris Biopharma Holdings, Inc.: 25000 units of Common Stock, dated 2026-11-02. The full Form 4 contains 1 transaction entry.
